New Issue of NCCIH Update: NCCIH's role in HEAL funding; preapplication webinars for natural product drug interaction research

Announcements

NCCIH Director's Messages: NIH Rolls Out Large Wave of NIH HEAL Initiative Funding -- NCCIH's Ongoing Role September 26, 2019 Today, NIH announced that it has awarded $945 million in research to tackle the national opioid crisis through the Helping to End Addiction Long-term InitiativeSM, or the NIH HEAL InitiativeSM. The funds will be used for grants, contracts, and cooperative agreements across 41 states. The NIH HEAL Initiative is a trans-NIH research effort that has the goal of improving treatments for chronic pain, while curbing the rates of opioid use disorder and overdose and achieving long-term recovery from opioid addiction.

New Funding Opportunities for Natural Product Drug Interaction Research: Preapplication Webinars on October 3 Craig Hopp, Ph.D. September 25, 2019 Americans consume natural products every day either through their diet or via dietary supplements. The 2012 National Health Interview Survey estimates that 18 percent of adults in the United States use non-vitamin, non-mineral natural products as supplements. An estimated 20 to 30 percent of patients on prescription medication indicate they are also taking dietary supplements concomitantly.

NCCIH Director's Statement for U.S. House of Representatives Appropriations Committee, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies

On September 25, Dr. Helene Langevin provided a statement on the work done at the NCCIH. The written version is available on our website. 

---

Resources for Researchers

Notice of Two Pre-Application Webinars: “Preclinical Screening for Natural Product Drug Interactions (R21)” and “Center of Excellence for Natural Product Drug Interaction Research (U54)”

October 3, 2019

The intent of the webinars is to provide an overview of each of the initiatives and to address applicant questions prior to preparing and submitting applications. The webinars are optional and not required for application submission.

2019 NIH Director’s Awards for High-Risk, High-Reward Research Program Announced  (NIH)

October 1, 2019
The National Institutes of Health awarded 93 grants through its High-Risk, High-Reward Research Program that will fund highly innovative biomedical or behavioral research proposed by extraordinarily creative scientists.

---

Upcoming Events

Pain Lecture: Opioids and Cannabinoids in Pain: What We Don’t Know About Presynaptic GPCRs Is Hurting Us 

October 10, 2019; Building 49, Room 1A51/1A59, NIH Campus, Bethesda, MD. (In-person attendance only.)

Save the Date! 2020 International Congress on Integrative Medicine and Health is April 28, 2020

The International Congress on Integrative Medicine and Health will take place at the Hilton Cleveland Downtown in Cleveland, Ohio on April 28 - May 1, 2020. The Congress is convened by the Academic Consortium for Integrative Medicine and Health, in association with the International Society for Complementary Research. 

The deadline for abstract or proposal submissions is October 11, 2019.

---

In case you missed it...

Watch "NCCIH at 20: A Catalyst for Integrative Health Research"

The September 23 symposium celebrated progress in complementary and integrative health research and considered the future of the field. The day featured a Stephen E. Straus Distinguished Lecture in the Science of Complementary Therapies by Dr. Lorimer Moseley of the University of South Australia titled “Why We Need a Pain Revolution: From Science to Practice,” lightning round presentations with early-stage investigators, and two panel discussions on pain research in military and veteran populations as well as the future of natural products research. View the archive.

We Are Recruiting! Position Opening for Clinical Director, Division of Intramural Research Application Deadline: October 16, 2019 NCCIH is seeking an exceptional and motivated leader to serve as the Clinical Director/Supervisory Physician (Clinical) within the Clinical Investigation Branch  in the Division of Intramural Research (DIR). The NCCIH DIR conducts basic, translational, and clinical research to improve our understanding of neural mechanisms of pain processing and nonpharmacologic modulation of pain. DHHS, NIH, and NCCIH are equal opportunity employers. Applications from women, minorities, and persons with disabilities are strongly encouraged.